Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

EXP6155

Known as: 1H-Imidazole-5-acetic acid, 2-butyl-1-((4-carboxyphenyl)methyl)-4-chloro-, disodium salt, EXP 6155, EXP-6155 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1991
Review
1991
Some simple JV-benzylimidazoles, originally described by Takeda Chemical Industries (Osaka, Japan), were characterized to be very… Expand
  • figure 1
  • figure 3
  • table 1
  • figure 2
  • figure 4
Is this relevant?
Review
1990
Review
1990
Although the most direct way to interfere with the renin-angiotensin system (RAS) is at the level of the angiotensin II (AII… Expand
Is this relevant?
Review
1990
Review
1990
The most direct approach to block the function of the renin-angiotensin system would be to antagonize angiotensin II (AII) at the… Expand
Is this relevant?
1989
1989
EXP6155 (2-n-butyl-l-[4-carboxybenzyl]-4-chloroimidazole-5-acetic acid) and EXP6803 (methyl 2-n-butyl-l-[4-(2-carfooxybenzamido… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
1989
1989
A series of 1-benzylimidazole-5-acetate derivatives defining the critical substituents on the phenyl ring was synthesized in… Expand
Is this relevant?